Belite Bio (BLTE) Competitors $87.58 +6.32 (+7.77%) As of 03:52 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock BLTE vs. ELAN, VRNA, RVMD, ABVX, RNA, CYTK, MRUS, RYTM, CRSP, and GRFSShould you be buying Belite Bio stock or one of its competitors? The main competitors of Belite Bio include Elanco Animal Health (ELAN), Verona Pharma PLC American Depositary Share (VRNA), Revolution Medicines (RVMD), Abivax (ABVX), Avidity Biosciences (RNA), Cytokinetics (CYTK), Merus (MRUS), Rhythm Pharmaceuticals (RYTM), CRISPR Therapeutics (CRSP), and Grifols (GRFS). These companies are all part of the "pharmaceutical products" industry. Belite Bio vs. Its Competitors Elanco Animal Health Verona Pharma PLC American Depositary Share Revolution Medicines Abivax Avidity Biosciences Cytokinetics Merus Rhythm Pharmaceuticals CRISPR Therapeutics Grifols Belite Bio (NASDAQ:BLTE) and Elanco Animal Health (NYSE:ELAN) are both medical companies, but which is the better stock? We will compare the two companies based on the strength of their risk, analyst recommendations, institutional ownership, media sentiment, valuation, dividends, earnings and profitability. Is BLTE or ELAN more profitable? Elanco Animal Health has a net margin of 9.68% compared to Belite Bio's net margin of 0.00%. Elanco Animal Health's return on equity of 7.04% beat Belite Bio's return on equity.Company Net Margins Return on Equity Return on Assets Belite BioN/A -34.90% -33.56% Elanco Animal Health 9.68%7.04%3.45% Which has preferable earnings and valuation, BLTE or ELAN? Elanco Animal Health has higher revenue and earnings than Belite Bio. Belite Bio is trading at a lower price-to-earnings ratio than Elanco Animal Health, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioBelite BioN/AN/A-$36.14M-$1.55-56.50Elanco Animal Health$4.48B2.27$338M$0.8623.81 Do institutionals & insiders have more ownership in BLTE or ELAN? 0.5% of Belite Bio shares are held by institutional investors. Comparatively, 97.5% of Elanco Animal Health shares are held by institutional investors. 13.3% of Belite Bio shares are held by insiders. Comparatively, 0.9% of Elanco Animal Health shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth. Does the media favor BLTE or ELAN? In the previous week, Elanco Animal Health had 5 more articles in the media than Belite Bio. MarketBeat recorded 11 mentions for Elanco Animal Health and 6 mentions for Belite Bio. Belite Bio's average media sentiment score of 0.70 beat Elanco Animal Health's score of 0.61 indicating that Belite Bio is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Belite Bio 2 Very Positive mention(s) 2 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Elanco Animal Health 4 Very Positive mention(s) 4 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Which has more risk & volatility, BLTE or ELAN? Belite Bio has a beta of -1.46, meaning that its stock price is 246% less volatile than the S&P 500. Comparatively, Elanco Animal Health has a beta of 1.65, meaning that its stock price is 65% more volatile than the S&P 500. Do analysts recommend BLTE or ELAN? Belite Bio presently has a consensus price target of $96.00, suggesting a potential upside of 9.62%. Elanco Animal Health has a consensus price target of $19.14, suggesting a potential downside of 6.51%. Given Belite Bio's higher possible upside, analysts clearly believe Belite Bio is more favorable than Elanco Animal Health.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Belite Bio 1 Sell rating(s) 1 Hold rating(s) 4 Buy rating(s) 0 Strong Buy rating(s) 2.50Elanco Animal Health 0 Sell rating(s) 3 Hold rating(s) 6 Buy rating(s) 2 Strong Buy rating(s) 2.91 SummaryElanco Animal Health beats Belite Bio on 13 of the 16 factors compared between the two stocks. Get Belite Bio News Delivered to You Automatically Sign up to receive the latest news and ratings for BLTE and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding BLTE and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart BLTE vs. The Competition Export to ExcelMetricBelite BioMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$2.77B$3.38B$6.14B$10.45BDividend YieldN/A2.30%5.73%4.78%P/E Ratio-56.1122.9585.0627.10Price / SalesN/A428.48570.65176.64Price / CashN/A46.1137.3961.86Price / Book18.5510.4812.406.66Net Income-$36.14M-$52.47M$3.32B$276.79M7 Day Performance11.56%-0.91%-0.23%-1.40%1 Month Performance30.90%14.63%9.56%5.64%1 Year Performance56.44%14.38%71.76%37.04% Belite Bio Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)BLTEBelite Bio1.6982 of 5 stars$87.58+7.8%$96.00+9.6%+46.5%$2.77BN/A-56.1110News CoverageHigh Trading VolumeELANElanco Animal Health2.7807 of 5 stars$20.04+1.4%$19.14-4.5%+47.1%$9.82B$4.44B23.309,000Analyst RevisionVRNAVerona Pharma PLC American Depositary Share1.4602 of 5 stars$106.91flat$109.00+2.0%N/A$9.21B$42.28M-107.9930Positive NewsRVMDRevolution Medicines4.2591 of 5 stars$48.75+1.1%$74.64+53.1%+1.2%$9.02B$11.58M-10.83250Analyst ForecastInsider TradeABVXAbivax3.0125 of 5 stars$95.63+2.0%$114.25+19.5%+908.5%$7.30BN/A0.0061Analyst ForecastRNAAvidity Biosciences2.0073 of 5 stars$48.96-1.6%$68.32+39.5%+8.1%$7.26B$10.90M-13.75190CYTKCytokinetics3.8332 of 5 stars$59.59-0.7%$76.64+28.6%+13.4%$7.18B$18.47M-11.68250MRUSMerus0.8796 of 5 stars$94.85+0.5%$93.12-1.8%+84.9%$7.14B$36.13M-17.2537Short Interest ↓RYTMRhythm Pharmaceuticals3.0459 of 5 stars$100.770.0%$106.64+5.8%+116.9%$6.70B$130.13M-33.48140Analyst ForecastCRSPCRISPR Therapeutics1.6482 of 5 stars$68.29-6.5%$71.71+5.0%+49.5%$6.65B$37.31M-12.58460News CoverageAnalyst ForecastInsider TradeGRFSGrifols3.5834 of 5 stars$9.45+1.4%$10.30+9.0%+12.7%$6.41B$7.81B8.0823,822 Related Companies and Tools Related Companies ELAN Alternatives VRNA Alternatives RVMD Alternatives ABVX Alternatives RNA Alternatives CYTK Alternatives MRUS Alternatives RYTM Alternatives CRSP Alternatives GRFS Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:BLTE) was last updated on 10/16/2025 by MarketBeat.com Staff From Our PartnersURGENT: The Market's 3 Red Flags Are FlashingHere’s the uncomfortable truth: The smartest investors in the world are already preparing for a crash befor...StockEarnings | SponsoredYour Bank Account Is No Longer SafeWhat If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what ...Priority Gold | SponsoredOctober 16 Changes the Microchip Game — and InvestingWhile everyone's chasing the same AI plays, George Gilder is focused on something completely different. He ...Banyan Hill Publishing | SponsoredBuilding The Infrastructure for the Coming Financial ResetWhile China pushes nearly $1 trillion through its new digital currency, one emerging company is quietly buildi...Intellistake | SponsoredREVEALED: Something Big Happening Behind White House DoorsWhat I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredShots officially fired…Elon Musk just declared war on the wireless giants with a $17 billion spectrum deal that gives SpaceX the righ...Brownstone Research | SponsoredOut of 18,347 Cryptocurrencies... This is the ONLY OneThe Single Most Undervalued DeFi Protocol You've Never Heard Of If there's one cryptocurrency you should b...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Belite Bio, Inc. Sponsored ADR Please log in to your account or sign up in order to add this asset to your watchlist. Share Belite Bio With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
